
Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Is There a Step Up in the IPO?
Overland valuation then on top of that, you know, one can help but think that valuation's got a heading not only on the public side but also on the private side. You know, as we look at the distribution of post-money valuation, there's roughly a third that have post-money values below 300 million and another third that are closer to a billion plus. And again, I think when you go company by company, I think there's a better case to be made for upside for this class of 2023 IPO candidate.
Transcript
Play full episode